Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lycopene to Reduce Skin Toxicity in Colorectal Carcinoma Treated With Panitumumab
NCT03167268Phase 2Unknown
- Sponsor
- Ospedale San Carlo Borromeo
- Start
- Aug 2016
- Primary completion
- Jan 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lycopene in Skin Toxicity, sponsored by Ospedale San Carlo Borromeo. Status: unknown.
02
Drugs
lycopene
03
Conditions
Skin Toxicity
Beyond the preview
Go deeper on NCT03167268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167268.